BriaCell held shareholder meeting, approved resolutions, provided detailed voting results, and filed formal report.

From GlobeNewswire: 2025-02-05 18:15:47

BriaCell Therapeutics Corp. held its annual general meeting of shareholders, with 36.26% of issued shares voted. Shareholders approved resolutions including the re-appointment of auditors and the election of directors, with detailed voting results provided. The formal report on voting results will be filed on the Company’s SEDAR profile. BriaCell is a biotechnology company developing novel immunotherapies for cancer care. The press release contains forward-looking statements and details risks and uncertainties. Neither the Toronto Stock Exchange nor its Regulation Services Provider accepts responsibility for the release’s accuracy. Contact information for the Company, media relations, and investor relations is provided.



Read more at GlobeNewswire: BriaCell Therapeutics Corp. Announces Results of